DYRK1A and diabetes mellitus: Thus, our study showed that miR-221-3p inhibits the synthesis of inflammatory factors in skin wounds generated in an animal model of diabetes and that the infiltration of immune cells such as neutrophils and macrophages is mediated through the DYRK1A/STAT3 signaling pathway.